Role of Autophagy and Reactive Oxygen Species in Cancer Treatment: Principles and Current Strategies
暫譯: 自噬與活性氧在癌症治療中的角色：原則與當前策略

Dr. Neeraj Mishra is working as Professor and Head, Department of Pharmaceutics, in Amity Institute of Pharmacy, Gwalior since July 2019. He has around twenty years of teaching and research experience. He has more than 100 publications of International and National repute in recent concepts of novel drug delivery systems, localized drug delivery, targeted and controlled drug delivery of nanocarriers/ microparticles for the treatment of breast, colon cancer, and neurodegenerative disorders. Dr. Mishra more than 3500 citations with h- index 30. The total cumulative Impact Factor of his published papers is more than 300 (as per SCOPUS). He has also written 10 Books and 25 book chapters in Elsevier, Bentham, Springer and Wiley Publication etc. He has also been granted 3 international patents and 2 Indian patents. Dr. Mishra is recipient of "Distinguished Professor Award" 2019 from DST-NSTMIS, SPAICS, Indore, and M.P. in September 2019. Dr. Mishra has also received the "Outstanding Scientist Award '' 2020, 6th International Scientist Awards on Engineering, Science, and Medicine, 20-21 June 2020, Chennai, India. Dr. Mishra has received the "Distinguished Professor Award '' 2021 from Indian Pharmaceutical Association, MP State Branch, Indore. Dr Mishra has received Best Academician Award in the Indian Pharmacy Graduate Association, M.P. State International Conference held on 06th May 2023 at DAVV Auditorium, Indore, India.

Dr. Mishra worded as guest Editor of Thematic issue entitled "Nanoparticulate Carriers for the treatment of Infectious Diseases and Cancer", Current Molecular Pharmacology, Volume 14, 2021, Issue number 3, Bentham Sciences, IF 3.3. Dr. Mishra got place in Stanford University Scientists Rankings conducted by AD Scientific Index - World Scientists Rankings - 2024 and 2022.

Dr. Ravinder Kumar Kaundal is a highly distinguished researcher in the field of pharmacology and toxicology. He completed his MS (Pharm.) and Ph.D. in Pharmacology and Toxicology at NIPER-SAS Nagar, India, where he developed a strong foundation in the pharmaceutical sciences. Dr. Ravinder is working as Assistant Professor in National Institute of Pharmaceutical Education and Research, Raebareli.

尼拉吉·米什拉博士自2019年7月以來在瓦爾基爾的阿米提藥學院擔任藥劑學系教授及系主任。他擁有約二十年的教學和研究經驗。在新型藥物傳遞系統、局部藥物傳遞、針對性和控制釋放的納米載體/微粒在乳腺癌、結腸癌及神經退行性疾病治療中的應用等最新概念方面，他擁有超過100篇國際和國內知名的出版物。米什拉博士的引用次數超過3500次，h指數為30。他發表的論文總累積影響因子超過300（根據SCOPUS）。他還在Elsevier、Bentham、Springer和Wiley等出版機構撰寫了10本書和25章書籍。他已獲得3項國際專利和2項印度專利。米什拉博士於2019年9月獲得了來自印度中央政府科技部（DST-NSTMIS）、SPAICS、印多爾的“傑出教授獎”2019。他還於2020年6月20日至21日在印度金奈的第六屆國際工程、科學和醫學科學家獎中獲得了“傑出科學家獎”2020。米什拉博士於2021年獲得了來自印度藥學協會（MP州分會、印多爾）的“傑出教授獎”。米什拉博士在2023年5月6日於印度印多爾的DAVV禮堂舉行的印度藥學研究生協會國際會議上獲得了最佳學者獎。

米什拉博士擔任《當前分子藥理學》期刊第14卷第3期的特刊《用於治療傳染病和癌症的納米顆粒載體》的客座編輯，該期刊由Bentham Sciences出版，影響因子為3.3。米什拉博士在斯坦福大學科學家排名中獲得了AD Scientific Index - 世界科學家排名 - 2024和2022的名次。

拉文德·庫馬·考恩達爾博士是藥理學和毒理學領域的傑出研究者。他在印度NIPER-SAS Nagar完成了藥學碩士（MS (Pharm.)）和藥理學及毒理學博士（Ph.D.），在此期間建立了堅實的藥學基礎。拉文德博士目前在國立藥學教育與研究所（National Institute of Pharmaceutical Education and Research）擔任助理教授。